Home/Filings/4/0001567619-19-021625
4//SEC Filing

Vaughn Jason 4

Accession 0001567619-19-021625

CIK 0001012477other

Filed

Nov 13, 7:00 PM ET

Accepted

Nov 14, 5:11 PM ET

Size

5.8 KB

Accession

0001567619-19-021625

Insider Transaction Report

Form 4
Period: 2019-10-22
Vaughn Jason
Sr. VP, Technical Operations
Transactions
  • Award

    Stock Option (right to buy)

    2019-10-22$3.45/sh+150,000$517,500150,000 total
    Exercise: $3.45Exp: 2029-10-22ADSs (150,000 underlying)
Footnotes (2)
  • [F1]Options become exercisable as to 37,500 ADSs on each of the first four anniversaries after the 10/22/2019 grant date.
  • [F2]The issuer's "ADSs" are American Depositary Shares, with each ADS representing one ordinary share, nominal value $0.01 per share, of the issuer; ADSs may be represented by American Depositary Receipts.

Documents

1 file

Issuer

AVADEL PHARMACEUTICALS PLC

CIK 0001012477

Entity typeother

Related Parties

1
  • filerCIK 0001793976

Filing Metadata

Form type
4
Filed
Nov 13, 7:00 PM ET
Accepted
Nov 14, 5:11 PM ET
Size
5.8 KB